Harbor Capital Advisors Inc. lifted its position in shares of DocGo Inc. (NASDAQ:DCGO – Free Report) by 144.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 968,537 shares of the company’s stock after purchasing an additional 572,522 shares during the period. Harbor Capital Advisors Inc.’s holdings in DocGo were worth $3,216,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Isthmus Partners LLC lifted its holdings in DocGo by 32.4% during the 2nd quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock worth $25,000 after buying an additional 195,428 shares during the last quarter. nVerses Capital LLC boosted its holdings in DocGo by 151.5% in the second quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after purchasing an additional 5,000 shares in the last quarter. Gladius Capital Management LP purchased a new position in DocGo in the second quarter valued at approximately $34,000. Nisa Investment Advisors LLC raised its holdings in DocGo by 693.2% during the second quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock worth $37,000 after purchasing an additional 10,565 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of DocGo during the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
DocGo Price Performance
Shares of NASDAQ:DCGO opened at $3.63 on Monday. The stock has a market cap of $371.41 million, a P/E ratio of 12.96, a P/E/G ratio of 2.99 and a beta of 0.89. DocGo Inc. has a 1-year low of $2.75 and a 1-year high of $6.90. The firm has a fifty day moving average price of $3.45 and a 200 day moving average price of $3.32.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on DCGO. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research report on Friday, September 20th. Needham & Company LLC reiterated a “buy” rating and set a $7.00 target price on shares of DocGo in a research report on Thursday, August 8th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $6.10.
Read Our Latest Analysis on DocGo
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- How to Use the MarketBeat Dividend Calculator
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Roth IRA Calculator: Calculate Your Potential Returns
- Battle of the Retailers: Who Comes Out on Top?
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.